OLR1 and endothelial dysfunction: Our study shows that elevated sLOX‐1 is an independent risk factor for poor prognosis in ACI and can be used to predict long‐term functional outcome of ACI, which may be related to the role of LOX‐1 in causing endothelial dysfunction, plaque initiation, progression, and instability (Huang et al., 2017; Li et al., 2018).